Patents by Inventor Magdalena Glice

Magdalena Glice has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline polymorphs of methanesulfonic acid addition salts of Imatinib
    Patent number: 7732601
    Abstract: This invention relates to the methanesulfonic acid addition salts of Imatinib and to the synthesis thereof. In particular, this invention relates to the synthesis of crystalline ?-form of Imatinib methanesulfonate. Furthermore, the invention is directed to a novel acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide with two molecules of methanesulfonic acid and to the polymorphic forms thereof, as well as to their pharmaceutical compositions.
    Type: Grant
    Filed: April 2, 2005
    Date of Patent: June 8, 2010
    Assignee: Instytut Farmaceutyczny
    Inventors: Wojciech Szczepek, Dorota Samson-Lazinska, Bogdan Zagrodzki, Magdalena Glice, Wioleta Maruszak, Katarzyna Korczak, Ryszard Modzelewski, Marta Lawecka, Lukasz Kaczmarek, Wieslaw Szelejewski, Urszula Fraczek, Piotr Cmoch
  • Methods for preparation of olanzapine polymorphic form I
    Patent number: 7538213
    Abstract: The invention relates to the methods for preparation of olanzapine polymorphic Form I. The invention also provides new mixed solvates of olanzapine, which are valuable intermediates used in the preparation of pure olanzapine polymorphic Form I.
    Type: Grant
    Filed: May 16, 2003
    Date of Patent: May 26, 2009
    Assignee: Institut Farmaceutyczny
    Inventors: Janina Piechaczek, Magdalena Glice, Urszula Fraczek, Jadwiga Serafin, Wieslaw Szelejewski, Krzysztof Soltysiak
  • Crystalline Polymorphs Of Methanesulfonic Acid Addition Salts Of Imatinib
    Publication number: 20070197545
    Abstract: This invention relates to the methanesulfonic acid addition salts of Imatinib and to the synthesis thereof. In particular, this invention relates to the synthesis of crystalline ?-form of Imatinib methanesulfonate. Furthermore, the invention is directed to a novel acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide with two molecules of methanesulfonic acid and to the polymorphic forms thereof, as well as to their pharmaceutical compositions.
    Type: Application
    Filed: April 2, 2005
    Publication date: August 23, 2007
    Applicant: INSTYTUT FARMACEUTYCZNY
    Inventors: Wojciech Szczepek, Dorota Samson-Lazinska, Bogdan Zagrodzki, Magdalena Glice, Wioleta Maruszak, Kataryzna Korczak, Ryszard Modzelewski, Marta Lawecka, Lukasz Kaczmarek, Wieslaw Szelejewski, Urszula Fraczek, Piotr Cmoch
  • METHODS FOR PREPARATION OF OLANZAPINE POLYMORPHIC FORM I
    Publication number: 20050239772
    Abstract: The invention relates to the methods for preparation of olanzapine polymorphic Form I. The invention also provides new mixed solvates of olanzapine, which are valuable intermediates used in the preparation of pure olanzapine polymorphic Form I.
    Type: Application
    Filed: May 16, 2003
    Publication date: October 27, 2005
    Applicant: Institut Farmaceutyczny
    Inventors: Janina Piechaczek, Magdalena Glice, Urszala Fraczek, Jadwiga Serafin, Wieslaw Szelejewski, Krzysztof Soltysiak